
    
      The purpose of this research study is to measure adherence to the study drug for the
      treatment of actinic keratoses. The study drug is 5-Fluorouracil (Carac®); it will be used in
      this study to treat actinic keratoses on the face and anterior scalp. This proposed study
      will evaluate adherence to topical Carac® in 20 adults age 50 or greater with actinic
      keratoses from a clinic population. Adherence data will be collected by the MEMS cap
      (Medication Event Monitoring System
    
  